Verrica Pharmaceuticals, Inc.
(NASDAQ : VRCA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.99%156.120.7%$1151.45m
PFEPfizer Inc. 0.50%34.370.9%$1063.61m
MRKMerck & Co., Inc. 1.34%73.140.7%$859.53m
BMYBristol-Myers Squibb Co. 1.75%60.381.0%$833.94m
ABBVAbbVie, Inc. 0.99%106.701.9%$716.41m
LLYEli Lilly & Co. 3.13%206.811.1%$635.54m
AZNAstraZeneca Plc 1.76%48.061.2%$486.33m
GSKGlaxoSmithKline Plc 1.84%34.910.2%$272.42m
NVSNovartis AG 0.64%84.030.2%$166.37m
SNYSanofi 1.50%46.590.2%$163.16m
VTRSViatris, Inc. 2.36%13.910.0%$134.52m
VERUVeru, Inc. 1.15%12.330.0%$121.05m
KALVKalVista Pharmaceuticals, Inc. -2.16%30.880.4%$99.62m
NVONovo Nordisk A/S 0.58%69.620.1%$91.37m
CVACCureVac NV 1.67%82.690.0%$80.07m

Company Profile

Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product VP-102, is a proprietary topical therapy used in common skin indications including Molluscum contagiosum and Verruca Vulgaris. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.